Pathology & Laboratory Medicine

Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

Filter By Faculty

Filter by Principal Investigator

2003

Porcu P, Baiocchi RA, Magro C. Recent developments in the biology and therapy of T-cell and natural killer-cell lymphomas. Curr Opin Oncol. 2003;15(5):353-62.

Fournier E, Isakoff SJ, Ko K, Cardinale CJ, Inghirami GG, Li Z, et al. The B cell SH2/PH domain-containing adaptor Bam32/DAPP1 is required for T cell-independent II antigen responses. Curr Biol. 2003;13(21):1858-66.

Nuovo GJ, Plaza JA, Magro C. Rapid diagnosis of smallpox infection and differentiation from its mimics. Diagn Mol Pathol. 2003;12(2):103-7.

A Crowson N, Brown TJ, Magro CM. Progress in the understanding of the pathology and pathogenesis of cutaneous drug eruptions : implications for management. Am J Clin Dermatol. 2003;4(6):407-28.

Gotlib V, Darji J, Bloomfield K, Chadburn A, Patel A, Braunschweig I. Eosinophilic variant of chronic myeloid leukemia with vascular complications. Leuk Lymphoma. 2003;44(9):1609-13.

Gu L, Zheng H, Murray SA, Ying H, Xiao Z-. Deregulation of Cdc2 kinase induces caspase-3 activation and apoptosis. Biochem Biophys Res Commun. 2003;302(2):384-91.

Leibowitz SB, Garber JE, Fox EA, Loda M, Kaufman DS, Kantoff PW, et al. Male patients with diagnoses of both breast cancer and prostate cancer. Breast J. 2003;9(3):208-12.

Chiarle R, Gong JZ, Guasparri I, Pesci A, Cai J, Liu J, et al. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood. 2003;101(5):1919-27.

Zhang Y, Morrone G, Zhang J, Chen X, Lu X, Ma L, et al. CUL-4A stimulates ubiquitylation and degradation of the HOXA9 homeodomain protein. EMBO J. 2003;22(22):6057-67.

Stelow EB, Skeate R, Wahi MM, Langel D, Jessurun J. Invasive cutaneous verruco-cystic squamous cell carcinoma. A pattern commonly present in transplant recipients. Am J Clin Pathol. 2003;119(6):807-10.